Large-scale testing (Phase 3)Active Not RecruitingNCT07439055
What this trial is testing
Real-World Joint Outcomes After Selective Transition to Low-Dose Emicizumab in Pediatric Hemophilia A
Who this might be right for
Hemophilia A Patient
Chulalongkorn University 18